Current approaches to treatments for schizophrenia spectrum disorders, part I: an overview and medical treatments

WT Chien, ALK Yip - Neuropsychiatric disease and treatment, 2013 - Taylor & Francis
During the last three decades, an increasing understanding of the etiology,
psychopathology, and clinical manifestations of schizophrenia spectrum disorders, in …

Secondary parkinsonism due to drugs, vascular lesions, tumors, trauma, and other insults

M Höllerhage - International review of neurobiology, 2019 - Elsevier
In addition to neurodegenerative disorders, there are many secondary forms of
parkinsonism. The most common cause for secondary parkinsonism is the intake of distinct …

Incidence of drug-induced delirium during treatment with antidepressants or antipsychotics: a drug surveillance report of German-speaking countries between 1993 …

ME Friedrich, R Grohmann, U Rabl… - International Journal …, 2022 - academic.oup.com
Objectives Successful treatment of delirium depends on the detection of the reversible
contributors. Drugs with delirogenic properties are the most prevalent reversible cause of …

Pharmacogenetics of adverse events in schizophrenia treatment: comparison study of ziprasidone, olanzapine and perazine

P Tybura, B Trześniowska-Drukała, P Bienkowski… - Psychiatry …, 2014 - Elsevier
The primary aim of the present study was to assess the possible associations between
dopaminergic, serotonergic, and glutamatergic system-related genes and adverse events …

Which first-generation antipsychotics should be “repurposed” for the treatment of schizophrenia

S Leucht, JM Davis - European archives of psychiatry and clinical …, 2022 - Springer
In a previous editorial for the European Archives of Psychiatry and Clinical Neuroscience,
we concluded that most firstgeneration antipsychotics (FGAs) have been poorly studied in …

[HTML][HTML] Diretrizes da Federação Mundial das Sociedades de Psiquiatria Biológica para o tratamento biológico da esquizofrenia. Parte 1: tratamento agudo

P Falkai, T Wobrock, J Lieberman… - Archives of Clinical …, 2006 - SciELO Brasil
Estas diretrizes para o tratamento biológico da esquizofrenia foram desenvolvidas pela
Força-Tarefa da Federação Mundial das Sociedades de Psiquiatria Biológica (World …

Some dopaminergic genes polymorphisms are not associated with response to antipsychotic drugs in schizophrenic patients

P Tybura, A Samochowiec, A Beszlej, A Grzywacz… - Pharmacological …, 2012 - Elsevier
Background Therapeutic effects of all clinically used antipsychotics are related to the
reduction of dopaminergic transmission in the limbic system. The aim of present study was …

Effects of antipsychotics on insight in schizophrenia: results from independent samples of first-episode and acutely relapsed patients

B Misiak, D Frydecka, JA Beszlej… - International clinical …, 2016 - journals.lww.com
We aimed to investigate whether antipsychotics differentially impact insight and whether
these effects appear because of improvement in psychopathological manifestation in 132 …

Cytochrome P450‐mediated interaction between perazine and risperidone: implications for antipsychotic polypharmacy

M Paulzen, E Haen, C Hiemke… - British journal of …, 2017 - Wiley Online Library
Background Although clinically widespread, scientific evidence for antipsychotic
polypharmacy is still limited. Combining different drugs increases the potential for drug–drug …

Antipsychotic drugs v. barbiturates or benzodiazepines used as active placebos for schizophrenia: a systematic review and meta-analysis

S Siafis, G Deste, A Ceraso, C Mussoni, A Vita… - Psychological …, 2020 - cambridge.org
BackgroundComparisons of antipsychotics with placebo can be biased by unblinding due to
side effects. Therefore, this meta-analysis compared the efficacy of antipsychotics for acute …